Additional research with rigorous study designs and precise statistical analysis should be conducted to ascertain whether FH mutations with or without HLRCC increase the likelihood of infertility and which treatments result in higher success rates. The gene discussed is FH; the disease is hereditary leiomyomatosis and renal cell cancer.